PLoS ONE (Jan 2018)

Discriminatory performance of adiponectin and leptin in the identification of impaired glucose tolerance: The Guangzhou Biobank Cohort Study - Cardiovascular Disease Subcohort.

  • Konstantinos A Toulis,
  • Chao Q Jiang,
  • Karla Hemming,
  • Krishnarajah Nirantharakumar,
  • Kar K Cheng,
  • Tai H Lam,
  • G Neil Thomas

DOI
https://doi.org/10.1371/journal.pone.0206964
Journal volume & issue
Vol. 13, no. 11
p. e0206964

Abstract

Read online

BackgroundTo evaluate the additional discriminatory performance of adiponectin, leptin, and their ratio in the identification of impaired glucose tolerance (IGT) in men and women without diabetes on top of conventional risk factors.Methods & resultsA total of 698 subjects underwent an oral glucose tolerance test (oGTT) and adipocytokine measurements. A comprehensive stepwise selection procedure was performed, followed by c-statistics and integrated discrimination improvement (IDI) analysis. In males, adiponectin levels were significantly lower in the IGT group compared to the non-IGT group (Whitney U test, p ConclusionsIn Chinese individuals without diabetes, no significant evidence for the potential discriminatory value of adiponectin, leptin or their ratio in the identification of IGT on top of conventional risk factors was observed.